Viewing Study NCT06789432


Ignite Creation Date: 2025-12-24 @ 9:57 PM
Ignite Modification Date: 2026-05-02 @ 6:19 PM
Study NCT ID: NCT06789432
Status: RECRUITING
Last Update Posted: 2025-07-29
First Post: 2025-01-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Atorvastatin and Ezetimibe (10/10mg) Fixed Dose Combination Versus Atorvastatin (20mg) Monotherapy in Bangladeshi Population
Sponsor: Dr. Md. Alimur Reza
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: BEX2411001
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators